Short Interest in Aemetis, Inc. (NASDAQ:AMTX) Rises By 5.8%

Aemetis, Inc. (NASDAQ:AMTX - Get Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 5,670,000 shares, a growth of 5.8% from the November 30th total of 5,360,000 shares. Based on an average trading volume of 729,000 shares, the short-interest ratio is currently 7.8 days.

Hedge Funds Weigh In On Aemetis

Several large investors have recently made changes to their positions in AMTX. FMR LLC lifted its stake in Aemetis by 68.2% during the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company's stock valued at $52,000 after purchasing an additional 9,137 shares during the last quarter. Hutchinson Capital Management CA acquired a new stake in shares of Aemetis during the 2nd quarter valued at $70,000. Barclays PLC lifted its position in shares of Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company's stock valued at $109,000 after acquiring an additional 34,816 shares during the last quarter. Rhumbline Advisers boosted its stake in shares of Aemetis by 2,837.1% during the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company's stock worth $157,000 after acquiring an additional 50,528 shares in the last quarter. Finally, Wellington Management Group LLP acquired a new position in shares of Aemetis in the 3rd quarter worth $177,000. Institutional investors own 27.02% of the company's stock.

Aemetis Stock Down 4.3 %

AMTX traded down $0.12 during trading on Wednesday, reaching $2.69. The stock had a trading volume of 719,887 shares, compared to its average volume of 792,014. Aemetis has a 1-year low of $2.10 and a 1-year high of $7.03. The firm has a market capitalization of $133.79 million, a price-to-earnings ratio of -1.19 and a beta of 1.35. The stock has a 50 day moving average of $3.27 and a two-hundred day moving average of $2.98.

Aemetis (NASDAQ:AMTX - Get Free Report) last announced its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, beating the consensus estimate of ($0.47) by $0.09. The firm had revenue of $81.44 million during the quarter, compared to analyst estimates of $77.79 million. During the same quarter last year, the company earned ($0.59) EPS. On average, research analysts forecast that Aemetis will post -2.02 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. StockNews.com raised Aemetis to a "sell" rating in a report on Wednesday, December 25th. HC Wainwright reaffirmed a "buy" rating and issued a $28.00 target price on shares of Aemetis in a research report on Monday, December 23rd. Finally, Ascendiant Capital Markets cut their target price on Aemetis from $20.00 to $19.00 and set a "buy" rating on the stock in a research note on Tuesday, September 3rd. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the stock. According to MarketBeat, Aemetis presently has a consensus rating of "Moderate Buy" and an average target price of $12.95.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.